Understand how the water purification technology market addresses PFAS, microplastics, and pharmaceutical residues with electrocoagulation, providing a non-biological barrier that removes trace contaminants without membranes.
The universe of water contaminants is expanding, and regulators are responding with lower limits for more substances. The water purification technology market is exploring electrocoagulation as a treatment for emerging contaminants that challenge conventional methods. Per- and polyfluoroalkyl substances (PFAS), often called "forever chemicals," do not biodegrade and are poorly removed by conventional coagulation. Research has shown that electrocoagulation with iron or aluminum electrodes can remove a wide range of PFAS compounds, likely through adsorption onto the metal hydroxide flocs and electrooxidation at the electrode surface. For a community or industrial facility with PFAS-contaminated groundwater, electrocoagulation offers a treatment option that does not require the high pressure and membrane replacement costs of reverse osmosis, nor the energy intensity of granular activated carbon regeneration.
Microplastics are another emerging concern where electrocoagulation shows promise. The water purification technology market recognizes that conventional sand filtration and even membrane processes can be fouled or bypassed by microplastic particles. Electrocoagulation generates flocs that entrain microplastics, removing them from the water column. The gas bubbles produced during electrolysis (hydrogen and oxygen) also attach to microplastic particles, floating them to the surface for skimming. Pharmaceutical residues, including antibiotics and hormones, may be partially oxidized at high-voltage electrode surfaces, though complete mineralization typically requires more energy. For a hospital treating its wastewater, electrocoagulation can reduce the load of active pharmaceutical ingredients before discharge to a municipal sewer, protecting downstream aquatic life.
Integrating the water purification technology market with the electrocoagulation market reveals the importance of hybrid systems. Electrocoagulation alone may not remove all contaminants to very low limits, but it can be an excellent pretreatment for reverse osmosis or nanofiltration. By removing suspended solids, colloids, and scale-forming ions, electrocoagulation reduces membrane fouling and extends membrane life. For a water reuse project treating municipal wastewater, an electrocoagulation-ultrafiltration-reverse osmosis train can produce high-quality water for industrial or indirect potable reuse. The electrocoagulation step removes the organic and biological foulants that would otherwise clog the ultrafiltration membranes. As the list of regulated contaminants grows and discharge limits fall, the water purification technology market will continue to validate electrocoagulation as a versatile, chemical-free tool for producing clean water from increasingly challenging source waters.
Access detailed findings to navigate market complexities:
English